N-pVAX1

N-pVAX1 · Karolinska Institutet

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for N-pVAX1, covering 2026-03-23 to 2026-03-23. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate Safety and Immunogenicity of DNA Vaccine N-pVAX1 Against Crimean Congo Hemorrhagic Fever [Phase 1]

See pricing